cik
stringclasses 1
value | date
stringlengths 8
8
| form
stringclasses 4
values | sentenceCount
int64 0
2.33k
| sentence
stringlengths 2
5.25k
| filename
stringlengths 40
40
|
|---|---|---|---|---|---|
0000320193
|
20080201
|
10-Q
| 1,069
|
The Company regularly assesses the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of its provision for taxes.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,070
|
There can be no assurance that the outcomes from these examinations will not have a material adverse effect on the Company’s financial condition and operating results.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,071
|
The Company is subject to risks associated with the availability and coverage of insurance.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,072
|
For certain risks, the Company does not maintain insurance coverage because of cost and/or availability.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,073
|
Because the Company retains some portion of its insurable risks, and in some cases self-insures completely, unforeseen or catastrophic losses in excess of insured limits may have a material adverse effect on the Company’s financial condition and operating results.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,074
|
For additional discussion of these and other factors affecting the Company’s future results and financial condition, see Part I, Item 1, “Business” in the Company’s 2007 Form 10-K.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,075
|
Item 2.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,076
|
Unregistered Sales of Equity Securities and Use of Proceeds
On December 21, 2007, the Company issued 109,027 shares of its common stock to a privately held company in connection with an acquisition of assets.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,077
|
The offer and sale was made without any public offering or solicitation, and was exempt under Section 4(2) of the Securities Act of 1933, as amended.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,078
|
Item 6.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,079
|
Exhibits
(a) Index to Exhibits
Incorporated by
Reference
Exhibit
Number
Exhibit Description
Form
Filing Date/
Period End
Date
3.1
Restated Articles of Incorporation, filed with the Secretary of State of the State of California on January 27, 1988.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,080
|
S-3
7/27/88
3.2
Certificate of Amendment to Restated Articles of Incorporation, filed with the Secretary of State of the State of California on May 4, 2000.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,081
|
10-Q
5/11/00
3.3
Certificate of Amendment to Restated Articles of Incorporation, as amended, filed with the Secretary of State of the State of California on February 25, 2005.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,082
|
10-Q
3/26/05
3.4
Certificate of Determination of Preferences of Series A Non-Voting Convertible Preferred Stock of the Registrant.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,083
|
10-K
9/26/97
3.5
By-Laws of the Registrant, as amended through November 13, 2007.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,084
|
10-K
9/29/07
10.1*
Employee Stock Purchase Plan, as amended through May 10, 2007.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,085
|
8-K
5/16/07
10.2*
Form of Indemnification Agreement between the Registrant and each officer of the Registrant.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,086
|
10-K
9/26/97
10.3*
1997 Employee Stock Option Plan, as amended through October 19, 2001.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,087
|
10-K
9/28/02
10.4*
1997 Director Stock Option Plan, as amended through May 10, 2007.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,088
|
8-K
5/16/07
10.5*
2003 Employee Stock Plan, as amended through May 10, 2007.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,089
|
8-K
5/16/07
10.6*
Reimbursement Agreement dated as of May 25, 2001 by and between the Registrant and Steven P. Jobs.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,090
|
10-Q
6/29/02
10.7*
Form of Restricted Stock Unit Award Agreement.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,091
|
10-Q
3/27/04
10.8*
Alternative Form of Restricted Stock Unit Award Agreement.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,092
|
10-K
9/24/05
10.9*
Performance Bonus Plan dated April 21, 2005.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,093
|
10-Q
3/26/05
10.10*
Form of Election to Satisfy Tax Withholding with Stock.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,094
|
8-K
8/15/05
10.11*
Form of Option Agreements.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,095
|
10-K
9/24/05
10.12*
Consulting Agreement dated as of April 17, 2006 by and between the Registrant and J.R. Ruby Consulting Corp.
10-Q
7/1/06
10.13*
Form of Restricted Stock Unit Award Agreement effective as of August 28, 2007.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,096
|
10-K
9/29/07
14.1**
Business Conduct Policy of the Registrant dated January 2008.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,097
|
31.1**
Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,098
|
31.2**
Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,099
|
32.1***
Section 1350 Certifications of Chief Executive Officer and Chief Financial Officer.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,100
|
*
Indicates management contract or compensatory plan or arrangement.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,101
|
**
Filed herewith.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,102
|
***
Furnished herewith.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,103
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20080201
|
10-Q
| 1,104
|
January 31, 2008
APPLE INC.
By:
/s/ Peter Oppenheimer
Peter Oppenheimer
Senior Vice President and
Chief Financial Officer
|
0001193125-08-017426/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 0
|
10-Q aapl-20220326.htm 10-Q
aapl-20220326false2022Q20000320193--09-24P1Y63P1Y27P1Y82
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 26, 2022
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 1
|
Commission File Number: 001-36743
Apple Inc.
(Exact name of Registrant as specified in its charter)
California 94-2404110
(State or other jurisdiction
of incorporation or organization) (I.R.S.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 2
|
Employer Identification No.)
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 3
|
One Apple Park Way
Cupertino, California
(Address of principal executive offices) (Zip Code)
(408) 996-1010
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s) Name of each exchange on which registered
Common Stock, $0.00001 par value per share
AAPL
The Nasdaq Stock Market LLC
1.000% Notes due 2022 -
The Nasdaq Stock Market LLC
1.375% Notes due 2024 -
The Nasdaq Stock Market LLC
0.000% Notes due 2025 -
The Nasdaq Stock Market LLC
0.875% Notes due 2025 -
The Nasdaq Stock Market LLC
1.625% Notes due 2026 -
The Nasdaq Stock Market LLC
2.000% Notes due 2027 -
The Nasdaq Stock Market LLC
1.375% Notes due 2029 -
The Nasdaq Stock Market LLC
3.050% Notes due 2029 -
The Nasdaq Stock Market LLC
0.500% Notes due 2031 -
The Nasdaq Stock Market LLC
3.600% Notes due 2042 -
The Nasdaq Stock Market LLC
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 4
|
Yes ☒ No ☐
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 5
|
Yes ☒ No ☐
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 6
|
See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 7
|
Large accelerated filer ☒ Accelerated filer ☐
Non-accelerated filer ☐ Smaller reporting company ☐
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 8
|
☐
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 9
|
Yes ☐ No ☒
16,185,181,000 shares of common stock were issued and outstanding as of April 15, 2022.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 10
|
Apple Inc.
Form 10-Q
For the Fiscal Quarter Ended March 26, 2022
PART I - FINANCIAL INFORMATION
Item 1.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 11
|
Financial Statements
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
See accompanying Notes to Condensed Consolidated Financial Statements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 12
|
Apple Inc. | Q2 2022 Form 10-Q | 1
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
See accompanying Notes to Condensed Consolidated Financial Statements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 13
|
Apple Inc. | Q2 2022 Form 10-Q | 2
Apple Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands and par value)
See accompanying Notes to Condensed Consolidated Financial Statements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 14
|
Apple Inc. | Q2 2022 Form 10-Q | 3
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (Unaudited)
(In millions, except per share amounts)
See accompanying Notes to Condensed Consolidated Financial Statements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 15
|
Apple Inc. | Q2 2022 Form 10-Q | 4
Apple Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
See accompanying Notes to Condensed Consolidated Financial Statements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 16
|
Apple Inc. | Q2 2022 Form 10-Q | 5
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 - Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”).
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 17
|
Intercompany accounts and transactions have been eliminated.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 18
|
In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 19
|
The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 20
|
Actual results could differ materially from those estimates.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 21
|
Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 22
|
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and accompanying notes included in its Annual Report on Form 10-K for the fiscal year ended September 25, 2021.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 23
|
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 24
|
An additional week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 25
|
The Company’s fiscal years 2022 and 2021 span 52 weeks each.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 26
|
Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 27
|
Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 26, 2022 and March 27, 2021 (net income in millions and shares in thousands):
Apple Inc. | Q2 2022 Form 10-Q | 6
Note 2 - Revenue
Net sales disaggregated by significant products and services for the three- and six-month periods ended March 26, 2022 and March 27, 2021 were as follows (in millions):
(1)Products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 28
|
(2)Wearables, Home and Accessories net sales include sales of AirPods®, Apple TV®, Apple Watch®, Beats® products, HomePod mini®, iPod touch® and accessories.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 29
|
(3)Services net sales include sales from the Company’s advertising, AppleCare®, cloud, digital content, payment and other services.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 30
|
Services net sales also include amortization of the deferred value of services bundled in the sales price of certain products.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 31
|
(4)Includes $3.0 billion of revenue recognized in the three months ended March 26, 2022 that was included in deferred revenue as of December 25, 2021, $2.7 billion of revenue recognized in the three months ended March 27, 2021 that was included in deferred revenue as of December 26, 2020, $4.8 billion of revenue recognized in the six months ended March 26, 2022 that was included in deferred revenue as of September 25, 2021, and $4.1 billion of revenue recognized in the six months ended March 27, 2021 that was included in deferred revenue as of September 26, 2020.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 32
|
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 9, “Segment Information and Geographic Data” for the three- and six-month periods ended March 26, 2022 and March 27, 2021, except in Greater China, where iPhone revenue represented a moderately higher proportion of net sales.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 33
|
As of March 26, 2022 and September 25, 2021, the Company had total deferred revenue of $12.5 billion and $11.9 billion, respectively.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 34
|
As of March 26, 2022, the Company expects 63% of total deferred revenue to be realized in less than a year, 27% within one-to-two years, 8% within two-to-three years and 2% in greater than three years.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 35
|
Apple Inc. | Q2 2022 Form 10-Q | 7
Note 3 - Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company’s cash, cash equivalents and marketable securities by significant investment category as of March 26, 2022 and September 25, 2021 (in millions):
(1)Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 36
|
(2)Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 37
|
(3)As of March 26, 2022 and September 25, 2021, total marketable securities included $15.4 billion and $17.9 billion, respectively, that were restricted from general use, related to the European Commission decision finding that Ireland granted state aid to the Company, and other agreements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 38
|
Apple Inc. | Q2 2022 Form 10-Q | 8
The following table shows the fair value of the Company’s non-current marketable debt securities, by contractual maturity, as of March 26, 2022 (in millions):
Derivative Instruments and Hedging
The Company may use derivative instruments to partially offset its business exposure to foreign exchange and interest rate risk.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 39
|
However, the Company may choose not to hedge certain exposures for a variety of reasons, including accounting considerations or the prohibitive economic cost of hedging particular exposures.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 40
|
There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign exchange or interest rates.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 41
|
Foreign Exchange Risk
To protect gross margins from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, option contracts or other instruments, and may designate these instruments as cash flow hedges.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 42
|
The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 43
|
To protect the Company’s foreign currency-denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 44
|
The Company designates these instruments as either cash flow or fair value hedges.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 45
|
As of March 26, 2022, the Company’s hedged term debt- and marketable securities-related foreign currency transactions are expected to be recognized within 20 years.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 46
|
The Company may also enter into derivative instruments that are not designated as accounting hedges to protect gross margins from certain fluctuations in foreign currency exchange rates, as well as to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 47
|
Interest Rate Risk
To protect the Company’s term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 48
|
The Company designates these instruments as either cash flow or fair value hedges.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 49
|
The notional amounts of the Company’s outstanding derivative instruments as of March 26, 2022 and September 25, 2021 were as follows (in millions):
The gross fair values of the Company’s derivative assets and liabilities were not material as of March 26, 2022 and September 25, 2021.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 50
|
The gains and losses recognized in other comprehensive income/(loss) and amounts reclassified from accumulated other comprehensive income/(loss) to net income for the Company’s derivative instruments designated as cash flow hedges were not material in the three- and six-month periods ended March 26, 2022 and March 27, 2021.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 51
|
Apple Inc. | Q2 2022 Form 10-Q | 9
The carrying amounts of the Company’s hedged items in fair value hedges as of March 26, 2022 and September 25, 2021 were as follows (in millions):
The gains and losses on the Company’s derivative instruments designated as fair value hedges and the related hedged item adjustments were not material in the three- and six-month periods ended March 26, 2022 and March 27, 2021.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 52
|
Accounts Receivable
Trade Receivables
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized businesses and education, enterprise and government customers.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 53
|
The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 54
|
In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 55
|
These credit-financing arrangements are directly between the third-party financing company and the end customer.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 56
|
As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 57
|
The Company’s cellular network carriers accounted for 36% and 42% of total trade receivables as of March 26, 2022 and September 25, 2021, respectively.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 58
|
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture subassemblies or assemble final products for the Company.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 59
|
The Company purchases these components directly from suppliers.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 60
|
As of March 26, 2022, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 52% and 12%.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 61
|
As of September 25, 2021, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 52%, 11% and 11%.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 62
|
Note 4 - Condensed Consolidated Financial Statement Details
The following tables show the Company’s condensed consolidated financial statement details as of March 26, 2022 and September 25, 2021 (in millions):
Property, Plant and Equipment, Net
Other Non-Current Liabilities
Apple Inc. | Q2 2022 Form 10-Q | 10
Other Income/(Expense), Net
The following table shows the detail of other income/(expense), net for the three- and six-month periods ended March 26, 2022 and March 27, 2021 (in millions):
Note 5 - Debt
Commercial Paper
The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program.
|
0000320193-22-000059/full-submission.txt
|
0000320193
|
20220429
|
10-Q
| 63
|
The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases.
|
0000320193-22-000059/full-submission.txt
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.